Our clinical studies Investigator-Initiated Trials

Investigator-Initiated Trials

Please complete all the fields

Investigator contact information

Investigator name *

Address *

E-mail *

Tel *

Fax

Hospital / Institution /Organization / Study Group information

Name *

The Hospital / Institution Characterization * academic hospital/institution, medical association, scientific/professional, association, other

Leader / Board member *

Contact information of the Hospital / Institution / Organization/ Study Group *

Sponsor information (according to GCP-ICH)

Name of sponsor *

Address of sponsor *

E-Mail *

Telephone *

Study information

Date of application for support *

Study title *

Study protocol synopsis * Please insert the research rationale with introduction, hypothesis, study design, inclusion and exclusion criteria, primary and secondary endpoints, study methods, data analysis, potential risk vs benefit analysis, publication plan and key references.

Inclusion period

Please list the start and the end of the study, first and final data analyses dates.

Projected Study Start *

Projected Study End *

Initial Data analysis *

Final Data analysis *

Previous experience as investigator in clinical studies

Please list a summary of study experience.

Budget and drug supply requested from Oncopeptides AB

Insert below a description of proposed use of funding including if study drug is requested.

Total budget in USD *

Study drug requested (Y/N): *

The information submitted to Oncopeptides will be held confidential within the company

Welcome to Oncopeptides AB’s (publ) website. In order to optimize your use of our website we use cookies. A cookie is a text file stored on your computer. If you want more information about what a cookie is, what the purpose of the cookie is and how you can block or delete cookies, please read the our cookie guidelines “About cookies”. By continuing, you agree to our use of cookies.